Evotec SE
EVO4.070USD
+0.010+0.25%
收盘 10/31, 16:00（美东）报价延迟15分钟
1.45B总市值
亏损市盈率 TTM
关于 Evotec SE 公司
Evotec SE 是一家总部位于德国的药物研发公司。该公司通过与制药和生物技术公司、学术机构、患者组织和风险投资公司建立研究联盟和开发伙伴关系，致力于开发新药品。药物研发解决方案以按服务收费、综合药物研发联盟、开发伙伴关系、候选药物许可和咨询安排的形式提供。Evotec SE 的业务涉及多个领域，包括神经科学、糖尿病和糖尿病并发症、疼痛和炎症、肿瘤学、传染病、呼吸系统疾病和纤维化。其产品线涵盖一系列治疗领域，例如中枢神经系统失眠、慢性咳嗽、免疫学和炎症、女性健康子宫内膜异位症、肾病学、皮肤病、纤维化疾病和抗病毒等。
Evotec SE简介
公司代码EVO
公司名称Evotec SE
上市日期Oct 11, 1999
CEODr. Christian Wojczewski
员工数量4827
证券类型Ordinary Share
年结日Oct 11
公司地址Essener Bogen 7
城市HAMBURG
上市交易所OMX Nordic Exchange Stockholm AB - cash
国家Germany
邮编22419
电话4940560810
网址https://www.evotec.com/
公司代码EVO
上市日期Oct 11, 1999
CEODr. Christian Wojczewski
Evotec SE公司高管
名称
名称/职务
职务
持股
持股变动
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Mr. Wesley Wheeler
Mr. Wesley Wheeler
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mrs. Aurelie Dalbiez
Mrs. Aurelie Dalbiez
Chief People Officer, Member of the Management Board
Chief People Officer, Member of the Management Board
--
--
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Ms. Laetitia Rouxel
Ms. Laetitia Rouxel
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Mr. Wesley Wheeler
Mr. Wesley Wheeler
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2024
FY2023
暂无数据
地区USD
名称
营收
占比
United States
482.23M
55.94%
Switzerland
117.94M
13.68%
United Kingdom
100.06M
11.61%
Rest of the world
89.00M
10.32%
Germany
35.59M
4.13%
其他
37.16M
4.31%
业务
地区
暂无数据
股东统计
更新时间: 10月23日 周四
更新时间: 10月23日 周四
持股股东
股东类型
持股股东
持股股东
占比
Mubadala Investment Company PJSC
1.29%
BlackRock Institutional Trust Company, N.A.
0.37%
Wellington Management Company, LLP
0.34%
DCF Advisers, LLC
0.31%
Parametric Portfolio Associates LLC
0.09%
其他
97.60%
持股股东
持股股东
占比
Mubadala Investment Company PJSC
1.29%
BlackRock Institutional Trust Company, N.A.
0.37%
Wellington Management Company, LLP
0.34%
DCF Advisers, LLC
0.31%
Parametric Portfolio Associates LLC
0.09%
其他
97.60%
股东类型
持股股东
占比
Sovereign Wealth Fund
1.29%
Investment Advisor
0.93%
Investment Advisor/Hedge Fund
0.37%
Family Office
0.07%
Hedge Fund
0.02%
Research Firm
0.02%
其他
97.29%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
73
9.41M
2.65%
-714.44K
2025Q2
63
9.47M
2.67%
-519.54K
2025Q1
60
9.08M
2.56%
-923.30K
2024Q4
59
8.93M
2.52%
-1.38M
2024Q3
56
8.37M
2.36%
-3.56M
2024Q2
55
7.62M
2.15%
-2.08M
2024Q1
54
5.00M
1.41%
-5.55M
2023Q4
56
5.70M
1.61%
-517.14K
2023Q3
51
1.23M
0.35%
-5.15M
2023Q2
46
1.39M
0.39%
-4.97M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Mubadala Investment Company PJSC
4.60M
1.29%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.32M
0.37%
-184.93K
-12.32%
Jun 30, 2025
Wellington Management Company, LLP
1.21M
0.34%
-697.85K
-36.66%
Jun 30, 2025
DCF Advisers, LLC
1.11M
0.31%
+362.91K
+48.29%
Jun 30, 2025
Parametric Portfolio Associates LLC
303.50K
0.09%
+303.50K
--
Jun 30, 2025
WCM Investment Management
297.91K
0.08%
+297.91K
--
Jun 30, 2025
Pitcairn
261.18K
0.07%
+261.18K
--
Jun 30, 2025
Envestnet Asset Management, Inc.
91.66K
0.03%
+91.66K
--
Jun 30, 2025
Morgan Stanley Smith Barney LLC
69.63K
0.02%
+5.71K
+8.93%
Jun 30, 2025
AllianceBernstein L.P.
47.65K
0.01%
+28.58K
+149.81%
Jun 30, 2024
查看更多
持股ETF
更新时间: 10月6日 周一
更新时间: 10月6日 周一
机构名称
占比
iShares Biotechnology ETF
0.07%
ActivePassive International Equity ETF
0%
DFA Dimensional Intl Sustainability Core 1 ETF
0%
iShares Biotechnology ETF
占比0.07%
ActivePassive International Equity ETF
占比0%
DFA Dimensional Intl Sustainability Core 1 ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
